Patent Number: 8,575,125

Title: Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders

Abstract: The invention relates to a method for treating and/or preventing obesity and/or obesity-related disorders by administering to a subject in need thereof a selective inhibitor of cannabinoid type 2 (CB2) receptor expression.

Inventors: Deveaux; Vanessa (Vincennes, FR), Teixeira Clerc; Fatima (Rosny Sous Bois, FR), Manin; Sylvie (Maisons Alfort, FR), Lotersztajn; Sophie (Paris, FR), Mallat; Ariane (Paris, FR), Tran-Van-Nhieu; Jeanne (Saint Maur des Fosses, FR)

Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)

International Classification: A61K 48/00 (20060101); C07H 21/04 (20060101); C07H 21/02 (20060101); C12N 15/63 (20060101)

Expiration Date: 1/05/12017